Monoclonal Antibody Therapy KRMC offers monoclonal antibody therapy to eligible patients for treatment of COVID-19. This therapy involves a one-time intravenous (IV) infusion of the antibodies. Early intervention with this therapy can shorten the duration of symptoms and reduce the risk of severe illness and hospitalization..